AT417049T

Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists

Abstract

Type (I) of smoke alkaline acetyl choline receptor excited agent, which D,Ar1,E, and Ar2 as manual in the by defined, its on map isomers, pharmacy Shang can accept of salt, preparation method, contains the compounds of drug combination property, and using the smoke alkaline acetyl choline receptor excited agent treatment or prevention psychiatric, and intelligence injury illness, and Alzheimer's 's disease, and learning capacity insufficient, and cognitive insufficient, and attention insufficient, and memory missing, and Louis small body dementia, and attention insufficient caused of function hyperthyroidism, and anxiety, and schizophrenia , Mania or manic depressive disorder, Parkinson's disease, Huntington's disease and Tourette Syndrome, there is loss of cholinergic synaptic neurodegenerative illness, jet lag, nicotine addiction, smoking cessation, pain, ulcerative colitis or irritable bowel disease.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

22 members in 18 offices

This recordMember, by publication datePriority claim8 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
0202430SwedenA

Members22

Family members, oldest first
DocumentOfficeKind
CA2493920A1CanadaA1
WO2004016617A1World Intellectual Property Organization (WIPO)A1
AU2003248592A1AustraliaA1
MXPA05001583AMexicoA
NO20051259LNorwayL
BR0313234ABrazilA
EP1539765A1European Patent Office (EPO)A1
CN1678615AChinaA
US2005239774A1United States of AmericaA1
KR20060002727ARepublic of KoreaA
IL166416A0IsraelA0
HK1077571A1Hong Kong, ChinaA1
JP2006507241AJapanA
ZA200501226BSouth AfricaB
CN100343256CChinaC
NZ537882ANew ZealandA
AU2003248592B2AustraliaB2
EP1539765B1European Patent Office (EPO)B1
AT417049TThis recordAustriaT
ATE417049T1AustriaT1
DE60325234D1GermanyD1
ES2316848T3SpainT3